mRNA vaccines induce rapid antibody responses in mice
Abstract mRNA vaccines can be developed and produced quickly, making them prime candidates for immediate outbreak responses. Furthermore, clinical trials have demonstrated rapid protection following mRNA vaccination. Thus, we sought to investigate how quickly mRNA vaccines elicit antibody responses...
主要な著者: | Makda S. Gebre, Susanne Rauch, Nicole Roth, Janina Gergen, Jingyou Yu, Xiaowen Liu, Andrew C. Cole, Stefan O. Mueller, Benjamin Petsch, Dan H. Barouch |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Nature Portfolio
2022-08-01
|
シリーズ: | npj Vaccines |
オンライン・アクセス: | https://doi.org/10.1038/s41541-022-00511-y |
類似資料
-
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
著者:: Susanne Rauch, 等
出版事項: (2021-04-01) -
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses
著者:: Nicole Roth, 等
出版事項: (2022-08-01) -
mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice
著者:: Charlie Fricke, 等
出版事項: (2024-12-01) -
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models
著者:: Nicole Roth, 等
出版事項: (2023-01-01) -
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
著者:: Björn Corleis, 等
出版事項: (2023-02-01)